RegeneCore Biotech
Shanghai, China· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
A developer of innovative cell-based therapies for autoimmune disorders and regenerative applications.
Autoimmune DiseasesRegenerative Medicine
Technology Platform
Develops therapies based on adult stem cells and immunomodulatory cells, with capabilities in cell processing and potential genetic engineering.
Opportunities
The large unmet need in autoimmune diseases and the growing acceptance of cell therapies present a significant market opportunity.
Risk Factors
Faces substantial scientific, manufacturing, and regulatory hurdles inherent to complex cell-based products.
Competitive Landscape
Enters a highly competitive and rapidly evolving global cell therapy arena with many well-funded competitors.